Letrozole Kabi is a non-steroidal aromatase inhibitor agent used in hormonal therapy.

ATC-Code: L02BG05


  • Letrozole Kabi 2.5 mg


Letrozole Kabi is indicated for:

  • The first line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer
  • The treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy

Product Information

​Please note that this product may not be available in all countries due to different registration status.

Additionally, approved indications, contraindications, side effects, warnings and all over product characteristics may differ between countries. Therefore, always the text of the nationally registered and approved product information is binding! Furthermore, country specific regulatory considerations affect the information we can provide on our products.

If you require any information please contact your local organization.